Liver function and morphology after resuscitation from severe hemorrhagic shock with hemoglobin solutions or autologous blood

Critical Care Medicine

Volumn 24, Issue 4, 1996, Pages 663-671

  Eldridge, James ^a   Russell, Robert ^a,b   Christenson, Robert ^a   Sakamoto, Ron ^a   Williams, John ^a   Parr, Michael ^a   Trump, Benjamin ^a   Delaney, Paul ^a   Mackenzie, Colin F ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c Anesthesiology Research Laboratories   (United States)

Author keywords

blood substitutes; critical illness; hemoglobin; hemorrhage; liver; liver function tests; morphology; resuscitation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD AUTOTRANSFUSION; CONTROLLED STUDY; DOG; HEMORRHAGIC SHOCK; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION;

ACUTE DISEASE; ANIMALS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION, AUTOLOGOUS; DISEASE MODELS, ANIMAL; DOGS; DRUG EVALUATION, PRECLINICAL; HEMOGLOBINS; LIVER; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RESUSCITATION; SHOCK, HEMORRHAGIC; SOLUTIONS; TIME FACTORS;

EID: 0029924020     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199604000-00019     Document Type: Article

References (35)

1. Marks DH, Lynett JE, Letscher RM, et al: Pyridoxalated polymerized stroma-free hemoglobin solutions (SFHS-PP) as an oxygen carrying fluid replacement for hemorrhagic shock in dogs. Mil Med 1987; 152:265-271
2. Sprung J, Mackenzie CF, Barnas GM, et al: Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. Crit Care Med 1995; 23: 1540-1553
3. Nees JE, Hauser CJ, Shippy C, et al: Comparison of cardiorespiratory effects of crystalline hemoglobin, whole blood, albumin, and Ringer's lactate in the resuscitation of hemorrhagic shock in dogs. Surgery 1978; 83:639-647
4. Vlahakes GJ, Lee R, Jacobs EE, et al: Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. Thorac Cardiovasc Surg 1990; 100:379-388
5. Hauser CJ, Kaufman C, Frantz R, et al: Use of crystalline hemoglobin as replacement of RBC mass. Arch Surg 1982; 117:782-786
6. Hauser CJ, Shoemaker WC: Hemoglobin solution in the treatment of hemorrhagic shock. Crit Care Med 1982; 10: 283-287
7. Williams J, Mackenzie CF, Sprung J, et al: Cardiorespiratory variables following resuscitation from severe hemorrhagic shock (HS) using hemoglobin solutions (HbS). Abstr. Anesthesiology 1993; 79:A569
8. Kaplan HR, Murthy VS: Hemoglobin solution: A potential oxygen transporting plasma volume expander. Federation Proceedings 1975; 34:1461-1465
9. Jesch FH, Peters W, Hobbhahn J, et al: Oxygen transporting fluids and oxygen delivery with hemodilution. Crit Care Med 1982; 10:270-274
10. Sprung J, Mackenzie CF, Christenson R, et al: High colloid osmotic pressure may increase mortality following hemoglobin solutions (HbS) for hemorrhagic shock resuscitation. Abstr. Anesthesiology 1993; 79:A570
11. Rabiner SF, Helbert JR, Lopas H, et al: Evaluation of a stroma free hemoglobin solution for use as a plasma expander. J Exp Med 1967; 126:1127-1142
12. DeVenuto F, Zegna AI: Plasma oncotic pressure during and after blood exchange with crystalline hemoglobin solution. Surg Gynecol Obstet 1978; 147: 379-384
13. Friedman HI, DeVenuto F, Zuck F, et al: Histologic and ultrastructural effects of stroma-free hemoglobin solutions on rat liver, kidney, and brain. Surg Forum 1977; 28:3-5
14. Friedman HI, DeVenuto F: Morpho-logical effects of transfusions with hemoglobin solutions. Crit Care Med 1982; 10:288-296
15. Takahashi T, Iwasaki K, Malchesky PS, et al: The effect of single-dose infusion of pyridoxalated-hemoglobin-polyoxy-ethylene conjugate solution on canine renal function. Artif Organs 1991; 15: 462-473
16. Schuschereba ST, Friedman HI, DeVenuto FN: Morphologic effects on the retina of massive exchange transfusion with a stroma-free hemoglobin solution. Lab Invest 1983; 48:339-352
17. Burhop KE, Farrell L, Nigro C, et al: Effects of intravenous infusions of diaspirin cross linked hemoglobin (DCLHb) on sheep. Biomaterials, Artificial Cells and Immobilization Biotechnology 1992; 20:581-585
18. Kida Y, Seinosuke I, Gyoutoku Y, et al: Vascular responsiveness to various vasoactive substances after exchange transfusion with pyridoxalated hemoglobin polyoxylene conjugate (PHP) solution in anesthetized rats. Artif Organs 1991; 15:5-14
19. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
20. Snyder SH: Nitric Oxide: First in a new class of neurotransmitters. Science 1992; 257:494-496
21. Beach MC, Morley J, Spiryda L, et al: Effects of liposome encapsulated hemoglobin on the reticuloendothelial system. Biomaterials, Artificial Cells and Immobilization Biotechnology 1982; 20: 771-776
22. Rabinovici R, Rudoph AS, Ligler FS, et al: Trends in shock research: Liposome-encapsulated hemoglobin: An oxygen-carrying fluid. Circ Shock 1990; 32: 1-17
23. Rabinovici R, Rudolph AS, Vernick J, et al: A new salutary resuscitative fluid: Liposome encapsulated hemoglobin/ hypertonic saline solution. J Trauma 1993; 35:121-127
24. Friedman, HL, DeVenuto, Lollini L, et al: Morphological effects following massive exchange transfusion with a stroma-free hemoglobin solution I. Liver. Lab Invest 1978; 39:167-177
25. Anderson PJ. Niny J, Biro GP: Clearance of differentially labeled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues. Biomaterials, Artificial Cells and Immobilization Biotechnology 1992; 20: 781-787
26. Fratantoni JC: Points to consider in the safety evaluation of hemoglobin-based oxygen carriers. Transfusion 1990; 31: 369-371
27. Fratantoni JC: Points to consider on the efficacy evaluation of hemoglobin-and perfluorocarbon-based oxygen carriers. Transfusion 1994; 34:712-713
28. Yabuki A, Yamaji K, Ohki H, et al: Characterization of pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier. Transfusion 1994; 30:516-520
29. Takahashi T, Iwasaki K, Malchesky PS, et al: Renal effects of multiple infusion of pyridoxalated-hemoglobin-polyoxy-ethylene congugate (PHP) solutions in dogs. Artif Organs 1993; 17:153-163
30. Fuchinoue S, Nakajima I, Agishi T, et al: Evaluation of a pyridoxalated hemoglobin-polyoxyethylene conjugate solution as a perfusate for liver preservation. Trans Am Soc Artif Intern Organs 1987; 33: 390-394
31. Nakajima I, Fuchinoue S, Teraoka S, et al: Long-term liver preservation using artificial blood substitute. Transplant Proc 1989; 21:1314-1315
32. Glick MR, Ryder KW, Jackson SA: Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32:470-475
33. Amberson WR, Flexner J, Steggerada FR, et al: On the use of Ringer-Locke solutions containing hemoglobin as a substitute for normal blood in animals. Journal of Cellular and Comparative Physiology 1934; 5:539-546
34. Bosman RJ, Minter J, Liu HR, et al: Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Anesth Analg 1992; 75:811-817
35. Mackenzie CF, Parr M, Christenson R, et al: The effect of free hemoglobin solutions on coagulation and hematology after resuscitation from severe hemorrhagic shock in dogs. Abstr. Anesthesiology 1993; 79:A269